| Taxane-induced blockade to nuclear accumulation of the androgen receptor predicts clinical responses in metastatic prostate cancer MS Darshan, MS Loftus, M Thadani-Mulero, BP Levy, D Escuin, XK Zhou, ... Cancer research 71 (18), 6019-6029, 2011 | 484 | 2011 |
| HFT-T, a targeting nanoparticle, enhances specific delivery of paclitaxel to folate receptor-positive tumors X Wang, J Li, Y Wang, KJ Cho, G Kim, A Gjyrezi, L Koenig, ... ACS nano 3 (10), 3165-3174, 2009 | 203 | 2009 |
| A folate receptor-targeting nanoparticle minimizes drug resistance in a human cancer model X Wang, J Li, Y Wang, L Koenig, A Gjyrezi, P Giannakakou, EH Shin, ... ACS nano 5 (8), 6184-6194, 2011 | 154 | 2011 |
| Expression of AR-V7 and ARv567es in Circulating Tumor Cells Correlates with Outcomes to Taxane Therapy in Men with Metastatic Prostate Cancer Treated in … ST Tagawa, ES Antonarakis, A Gjyrezi, G Galletti, S Kim, D Worroll, ... Clinical Cancer Research 25 (6), 1880-1888, 2019 | 112 | 2019 |
| Randomized, noncomparative, phase II trial of early switch from docetaxel to cabazitaxel or vice versa, with integrated biomarker analysis, in men with chemotherapy-naive … ES Antonarakis, ST Tagawa, G Galletti, D Worroll, K Ballman, ... Journal of Clinical Oncology 35 (28), 3181, 2017 | 83 | 2017 |
| Peloruside-and laulimalide-resistant human ovarian carcinoma cells have βI-tubulin mutations and altered expression of βII-and βIII-tubulin isotypes A Kanakkanthara, A Wilmes, A O'Brate, D Escuin, A Chan, A Gjyrezi, ... Molecular cancer therapeutics 10 (8), 1419-1429, 2011 | 49 | 2011 |
| Taxane resistance in prostate cancer is mediated by decreased drug-target engagement A Gjyrezi, F Xie, O Voznesensky, P Khanna, C Calagua, Y Bai, J Kung, ... The Journal of clinical investigation 130 (6), 3287-3298, 2020 | 48 | 2020 |
| The protein farnesyltransferase regulates HDAC6 activity in a microtubule-dependent manner J Zhou, CC Vos, A Gjyrezi, M Yoshida, FR Khuri, F Tamanoi, ... Journal of biological chemistry 284 (15), 9648-9655, 2009 | 46 | 2009 |
| Microtubule engagement with taxane is altered in taxane-resistant gastric cancer G Galletti, C Zhang, A Gjyrezi, K Cleveland, J Zhang, S Powell, ... Clinical Cancer Research 26 (14), 3771-3783, 2020 | 21 | 2020 |
| Androgen receptor nuclear localization correlates with AR-V7 mRNA expression in circulating tumor cells (CTCs) from metastatic castration resistance prostate cancer patients D Worroll, G Galletti, A Gjyrezi, DM Nanus, ST Tagawa, P Giannakakou Physical biology 16 (3), 036003, 2019 | 14 | 2019 |
| Investigation of taxol-resistance using folate-targeted ternary therapeutic nanoparticle K Cho, X Wang, G Kim, A Gjyrezi, P Giannakakou, S Nie, Z Chen, D Shin Cancer Research 67 (9_Supplement), 2311-2311, 2007 | 6 | 2007 |
| Zoledronic acid synergizes with Taxol in an HDAC6-dependent manner: novel mechanistic implications for combination anticancer therapy with taxanes A Gjyrezi, A O'Brate, C Chanel-Vos, P Giannakakou Cancer Research 67 (9_Supplement), 1425-1425, 2007 | 5 | 2007 |
| Androgen receptor variant shows heterogeneous expression in prostate cancer according to differentiation stage A Gjyrezi, G Galletti, J Zhang, D Worroll, M Sigouros, S Kim, V Cooley, ... Communications Biology 4 (1), 785, 2021 | 4 | 2021 |
| Baseline analysis of circulating tumor cell (CTC) enumeration and androgen receptor (AR) localization in men with metastatic castration-resistant prostate cancer (mCRPC) in … ST Tagawa, G Galletti, ES Antonarakis, S Tasaki, A Gjyrezi, D Worroll, ... Journal of Clinical Oncology 33 (15_suppl), 5031-5031, 2015 | 2 | 2015 |
| Liquid biopsy transcriptomics identify pathways associated with poor outcomes and immune phenotypes in men with mCRPC J Zhang, B Zimmermann, G Galletti, S Halabi, A Gjyrezi, Q Yang, S Gupta, ... Cancer Research 82 (12_Supplement), 646-646, 2022 | 1 | 2022 |
| Clinical Significance of AR-V567es in Prostate Cancer—Response ST Tagawa, ES Antonarakis, A Gjyrezi, G Galletti, P Giannakakou Clinical Cancer Research 25 (19), 6010-6011, 2019 | 1 | 2019 |
| Transferrin receptor identifies a distinct pool of circulating tumor cells from metastatic prostate cancer patients with unique molecular profiles enriched in AR variants A Gjyrezi, G Galletti, J Zhang, R Bareja, A Halima, D Worroll, D Nanus, ... Cancer Research 79 (13_Supplement), 451-451, 2019 | 1 | 2019 |
| ERG and AR-v7 involvement in taxane resistance of metastatic castration-resistant prostate cancers A Berger, S Kim, A Gjyrezi, G Galletti, A Sboner, MA Rubin, S Tagawa, ... Cancer Research 76 (14_Supplement), 2125-2125, 2016 | 1 | 2016 |
| 2563 Screening and baseline analysis of circulating tumor cell (CTC) counts and androgen receptor (AR) localization with clinical characteristics of men with metastatic … ST Tagawa, G Galletti, ES Antonarakis, S Tasaki, A Gjyrezi, D Worroll, ... European Journal of Cancer 3 (51), S498-S499, 2015 | 1 | 2015 |
| Blood-based transcriptomics provides novel insights into Sjögren's syndrome-associated lymphomagenesis A Gjyrezi, C Skarlis, P Zumbo, D Betel, IE Stergiou, M Voulgarelis, ... Cancer Research 84 (6_Supplement), 1404-1404, 2024 | | 2024 |
